RxDoctor Payments Data

Laertes Manuelidis, MD

Procedural Dermatology · Fort Myers, FLNPI 1245220698

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $197,339 of the $252,395 with a category attached, or 78.2%. Sun Pharmaceutical Industries Inc. accounts for 98.9% of it on its own, with 10 other manufacturers making up the rest. Among procedural dermatology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$252,395in general payments, 2019–2025

Across 291 payments — averaging $867.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$250K
  • UCB, Inc.$1K
  • Johnson & Johnson$460
  • AbbVie$403
  • Biofrontera Inc.$122
  • Lilly USA, LLC$103
  • plus $142 from 5 others

What the payments were for

  • Consulting fees$34,96914%
  • Speaking & faculty fees$197,33978%
  • Travel & lodging$13,1065%
  • Food & beverage$6,6163%
  • Education$3650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$252,395 in reported general payments places this provider in the 95th percentile of 60 procedural dermatology providers in Florida.

See all procedural dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$5,275,337
Medicare patients
4,945
Services billed
45,506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab13$48,083
XolairOmalizumab11$30,264
Clobetasol Propionate142$5,851
Clindamycin Phosphate79$3,117
Hydrocortisone158$2,282
Ketoconazole141$2,181
Triamcinolone Acetonide180$2,103
Fluorouracil24$1,913
Mometasone Furoate89$1,380
Gentamicin Sulfate41$1,370
Doxycycline Hyclate75$1,226
Mupirocin165$1,092
Metronidazole21$816
Fluocinonide14$635
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet18$604

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →